Table 2.
Comparison of people living with HIV in 25 countries with or without certain unmet needs in their communication with healthcare providers, among all participants (N = 2389)
| Exposure categories (N) and outcomes | Prevalence, % | χ2 statistic | P-value |
|---|---|---|---|
| Groups compared: With or without reported desire to be involved in treatment choices | |||
| Outcome assessed: HCP seeks my views about treatment before prescribing an HIV medication | 1.78 | 0.182 | |
| Among those with less desire to be involved (833) | 61.0 | ||
| Among those with more desire to be involved (1556) | 63.8 | ||
| Outcome assessed: HCP tells me about new HIV treatment options that become available | 8.66 | < 0.001 | |
| Among those with less desire to be involved (833) | 55.1 | ||
| Among those with more desire to be involved (1556) | 61.3 | ||
| Outcome assessed: I feel I understand enough about my HIV treatment | 20.77 | < 0.001 | |
| Among those with less desire to be involved (833) | 65.8 | ||
| Among those with more desire to be involved (1556) | 74.6 | ||
| Outcome assessed: I am given enough information to be involved in making choices about my HIV treatment | 1.19 | 0.276 | |
| Among those with less desire to be involved (833) | 61.1 | ||
| Among those with more desire to be involved (1556) | 63.4 | ||
| Groups compared: With or without report of side effects from ART | |||
| Outcome assessed: HCP asks me frequently about any side effects I might be experiencing with my HIV treatment | 3.16 | 0.075 | |
| Among those reporting no side effects from current ART (1348) | 64.5 | ||
| Among those reporting side effects from current ART (1041) | 61.0 | ||
| Outcome assessed: HCP asks me if I have any concerns about the HIV medication I am currently taking | 0.48 | < 0.001 | |
| Among those reporting no side effects from current ART (1348) | 64.5 | ||
| Among those reporting side effects from current ART (1041) | 65.9 | ||
| Outcome assessed: Comfortable discussing concerns about side effects of my HIV medication | 11.14 | 0.001 | |
| Among those reporting no side effects from current ART (1348) | 63.5 | ||
| Among those reporting side effects from current ART (1041) | 56.8 | ||
| Groups compared: With or without perception that HIV limits their daily life | |||
| Outcome assessed: Comfortable discussing concerns about the impact HIV is having on my life generally | 34.90 | < 0.001 | |
| Among those not perceiving that HIV has a negative impact on life (1448) | 61.3 | ||
| Among those with perception that HIV has a negative impact on life (941) | 49.0 | ||
| Groups compared: With or without reported privacy concerns (hiding/disguising HIV pills) | |||
| Outcome assessed: Comfortable discussing concerns about privacy and not disclosing my HIV status | 50.88 | < 0.001 | |
| Among those who never disguised/hid HIV pills (1006) | 60.5 | ||
| Among those who ever disguised/hid HIV pills (1383) | 45.8 | ||
| Groups compared: With or without report of suboptimal adherence to ART | |||
| Outcome assessed: Comfortable discussing concerns about skipping/missing medication or forgetting to take my pill(s) each day | 58.80 | < 0.001 | |
| Among those reporting optimal adherence (1814) | 60.6 | ||
| Among those reporting suboptimal adherence (575) | 42.4 | ||
| Groups compared: With or without perceived stress from daily ART intake | |||
| Outcome assessed: Comfortable discussing concerns about my emotional well-being | 51.73 | < 0.001 | |
| Among those not perceiving stress or anxiety from daily dosing schedule (1594) | 58.7 | ||
| Among those perceiving stress or anxiety from daily dosing schedule (795) | 43.1 | ||
| Groups compared: With or without report of any non-HIV comorbidity | |||
| Outcome assessed: Comfortable discussing concerns about long-term side effects of my HIV medication (e.g., problems with bones, kidneys, liver) | 27.61 | < 0.001 | |
| Among those not reporting any comorbidity (993) | 52.4 | ||
| Among those reporting ≥ 1 comorbidity (1396) | 63.1 | ||